SCHEMBL2713091

SCHEMBL2713091

NC(=O)c1cnc(Nc2cccc(OCC(=O)N3CCOCC3)c2)cc1N(c1ccccc1)C1CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.44
▸ ITK Q08881 1/20 0.44
▸ FKBP1A P62942 1/20 0.44
▸ ROCK2 O75116 1/20 0.43
▸ MAPT P10636 3/20 0.43
▸ PDE4B Q07343 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ TYK2 P29597 1/20 0.41
▸ JAK3 P52333 1/20 0.41
▸ IRAK4 Q9NWZ3 1/20 0.41
▸ CNR2 P34972 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ SYK P43405 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PDK2 Q15119 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2713052 0.92 MAPT (0.48) EGFRMAPTKDM4EKMT2AMEN1
SCHEMBL2714048 0.84 EGFR (0.45) EGFRITKFKBP1AROCK2MAPT
SCHEMBL2713777 0.84 SYK (0.44) PDE4BJAK2JAK1TYK2JAK3
SCHEMBL2694016 0.83 JAK3 (0.62) EGFRITKFKBP1AROCK2MAPT
SCHEMBL2714011 0.83 SYK (0.51) JAK2JAK1SYK
SCHEMBL2713291 0.83 JAK3 (0.45) JAK2JAK1TYK2JAK3IRAK4
SCHEMBL2715238 0.82 FAAH (0.42) KDM4EJAK2JAK1TYK2JAK3
SCHEMBL2713612 0.80 MAPK10 (0.55) SYK
SCHEMBL2715553 0.79 SYK (0.49) EGFRJAK2JAK1TYK2JAK3
SCHEMBL2695869 0.79 JAK3 (0.45) EGFRITKFKBP1AROCK2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635557-A2 NICOTINAMIDES AS JAK KINASE MODULATORS Portola Pharmaceuticals, Inc. (US) 2013-09-11 — — EP disclosed
WO-2012061428-A2 NICOTINAMIDES AS JAK KINASE MODULATORS PORTOLA PHARMACEUTICALS, INC. (US) 2012-05-10 — — WO disclosed
Send feedback